Thrombin receptor agonist peptide entrapped in poly(D,L)-lactide-co-glycolide microparticles: Preparation and characterization

References

• Abuharbeid S, Czubayko F, Aigner A. The fibroblast growth factor-binding protein FGF-BP. The International Journal of Biochemistry and Cell Biology 2006; 38: 1463–1468
   PubMed Web of Science ®Google Scholar
• Agawa Y, Yamamoto M, Takada S, Okada H, Shimamoto T. Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microparticles: Influence of molecular weight and copolymer rate of polymer. Chemical and Pharmaceutical Bulletin 1988; 36: 1502–1507
   PubMed Web of Science ®Google Scholar
• Bai XL, Yang YY, Chung TS, Ng S, Heller J. Effect of polymer composition on the fabrication of poly(ortho-ester) microspheres for controlled release of protein. Journal of Applied Polymer Science 2001; 80: 1630–1642
   Web of Science ®Google Scholar
• Bednar B, Condra C, Gould R, Connolly T. Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of agonists and antagonists. Thrombosis Research 1995; 77: 453–463
   PubMed Web of Science ®Google Scholar
• Castellanos IJ, Carrasquillo KG, Lopez JD, Alvarez M, Griebnow K. Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique. Journal of Pharmacy and Pharmacology 2001; 53: 167–178
   PubMed Web of Science ®Google Scholar
• Ceruso MA, McComsey DF, Leo GC, Andrade-Gordon P, Addo MF, Scarborough RM, Oksenberg D, Maryanoff BE. Thrombin receptor-activating peptide (TRAPs): Investigation of bioactive conformations via structure-activity, spectroscopic and computational studies. Bioorganic & Medicinal Chemistry 1999; 7: 2353–2371
   PubMed Web of Science ®Google Scholar
• Clark RAF. Wound repair: Overview and general considerations. The molecular and cellular biology of wound repair, RAF Clark. Plenum Press, London 1996; 3–50
   Google Scholar
• Cocks T, Mofatt J. Protease-activated receptors: Sentries for inflammation. Trends in Pharmacological Sciences 2000; 21: 103–108
   PubMed Web of Science ®Google Scholar
• Coughlin S. How the protease thrombin talks to cells. Proceedings of the National Academy of Sciences (USA) 1999; 96: 1023–1029
   Google Scholar
• Dejaeger NC, Tavernier BH. British Patent. (1, 405, 108), 1971
   Google Scholar
• Derian CK, Maryanoff BE, Andrade-Gordon P, Zhang HC. Design and evaluation of peptide-mimetic PAR-1 antagonists. Drug Development Research 2003; 59: 355–366
   Web of Science ®Google Scholar
• Dhanaraju MD, Jayakumar R, Vamsadhara C. Influence of manufacturing parameters on development of contraceptive steroid loaded injectable microspheres. Chemical and Pharmaceutical Bulletin 2004; 52: 976–979
   PubMed Web of Science ®Google Scholar
• Eckardt H, Ding M, Lind M, Hansen ES, Christensen KS, Hvid I. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. Journal of Bone and Joint Surgery 2005; 87: 1434–1438
   PubMedGoogle Scholar
• Ferrara N. VEGF as a therapeutic target in cancer. Oncology 2005; 3: 11–16
   Web of Science ®Google Scholar
• Geer D, Swartz D, Stelios T. Controlled delivery of keratinocyte growth factor promotes wound healing in vitro and in vivo. AIChE Annual Meeting. AIChE, New York, San Francisco, CA 2003; 100–102, 16–21 Nov 2003
   Google Scholar
• Hussain M, Beale G, Hughes M, Akhtar S. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer. The International Journal of Pharmacy 2002; 234: 129–138
   PubMed Web of Science ®Google Scholar
• Kim H, Burgess D. Effect of drug stability on analysis of release data from controlled release microspheres. Journal of Microencapsulation 2002; 19: 631–640
   PubMed Web of Science ®Google Scholar
• Kumanohoso T, Natsugoe S, Shimada M, Aikou T. Enhancement of therapeutic efficacy of bleomycin by incorporation into biodegradable poly-D,L-lactic acid. Cancer Chemotherapy & Pharmacology 1997; 40: 112–116
   PubMed Web of Science ®Google Scholar
• Mac A, Negi D, Friend D. Preparation and characterization of poly(styrene) microparticles containing corrosion inhibitors. Journal of Microencapsulation 1989; 6: 361–367
   PubMed Web of Science ®Google Scholar
• Markvicheva E, Dugina T, Grandfils Ch, Lange M, Stashevskaya K, Vasilieva T, Rumsh L, Strukova S. Application of bioencapsulated proteinases and peptides for wound healing. Advanced biomaterials for medical applications, Series II mathematics, physics and chemistry, DW Thomas. Kluwer Academic Publishers, Dordrecht, Boston, London 2004; 165–176
   Google Scholar
• Matzdorff AC, Kuhnel G, Kemkes-Matthes B, Voss R. Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer. Journal of Thrombosis and Thrombolysis 2001; 12: 129–139
   PubMed Web of Science ®Google Scholar
• Mikhailova AG, Likhareva VV, Vaskovsky BV, Garanin SK, Onoprienko LV, Prudchenko IA, Chikin LD, Rumsh LD. Study of secondary specificity of enteropeptidase in comparison with trypsin. Biochemistry 2004; 69: 909–917
   PubMed Web of Science ®Google Scholar
• Nihant N, Shugens Ch, Grandfils Ch, Jerome R, Teyssie Ph. Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability. Pharmaceutical Research 1994; 11: 1479–1484
   PubMed Web of Science ®Google Scholar
• Nihant N, Schugens Ch, Grandfils Ch, Jerome R, Teyssie Ph. Polylactide microparticles prepared by double emulsion-evaporation. II. Effect of poly(lactide-co-glycolide) composition on the stability of the primary and secondary emulsions. Journal of Colloid and Interface Science 1995; 173: 55–65
   Web of Science ®Google Scholar
• Richardson T, Petrs M, Ennett A, Mooney D. Polymeric system for dual growth factor delivery. Nature Biotechnology 2001; 19: 1029–1034
   PubMed Web of Science ®Google Scholar
• Ruomei Qi, Yutaka Y, Yukio O. Effect of incubation time, temperature and anticoagulants on platelet aggregation in whole blood. Thrombosis Research 2001; 101: 139–144
   PubMed Web of Science ®Google Scholar
• Singh M, Li XM, McGee JP, Zamb T, Koff W, Wang CY, O'hagan DT. Controlled release microparticles as a single dose hepatitis B vaccine: Evaluation of immunogenicity in mice. Vaccine 1997; 15: 475–481
   PubMed Web of Science ®Google Scholar
• Strukova S. Thrombin, a regulator of inflammation and reparative processes in tissues. Biochemistry 2001; 66: 8–18
   PubMed Web of Science ®Google Scholar
• Strukova S, Dugina T, Chistov I, Markvicheva M, Kuptsova SV, Kolokol'chikov EG, Rumsh LD, Zubov VP, Gluza E. Thrombin, a regulator of reparation processes in wound healing. Journal of Bioorganic Chemistry 1998; 24: 256–259
   Google Scholar
• Strukova SM, Dugina TN, Chistov IV, Lange M, Markvicheva EA, Kuptsova S, Zubov VP, Glusa E. Immobilized thrombin receptor agonist peptide accelerates wound healing in mice. Clinical and Applied Thrombosis/Hemostasis 2001; 7: 325–329
   PubMed Web of Science ®Google Scholar
• Takada Sh, Yamagata Y, Misaki M, Taira K, Kurokawa T. Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. Journal of Controlled Release 2003; 88: 229–242
   PubMed Web of Science ®Google Scholar
• Vrancken MN, Clays DA. United States Patent Office. (3, 526, 906), 1970
   Google Scholar
• Zhu KJ, Jiang HL, Du XY, Wang J, Xu WX, Liu SF. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique. Journal of Microencapsulation 2001; 18: 247–260
   PubMed Web of Science ®Google Scholar